Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia

Virchows Archiv

Volumn 459, Issue 1, 2011, Pages 41-46

  Kashima, Takeshi G ^a   Dongre, Arunthati ^a   Flanagan, Adrienne M ^b   Hogendoorn, Pancras C W ^c   Taylor, Richard ^a   Athanasou, Nicholas A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adamantinoma of long bone; Bone tumour; Fibrous dysplasia; Metastasis; Osteofibrous dysplasia; Podoplanin

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; PODOPLANIN; PROTEIN LYVE 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADAMANTINOMA OF LONG BONE; ADOLESCENT; ADULT; AMELOBLASTOMA; ARTICLE; BONE CANCER; BONE CARCINOMA; BONE DYSPLASIA; BONE METASTASIS; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OSTEOCYTE; OSTEOFIBROUS DYSPLASIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADAMANTINOMA; ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FIBROUS DYSPLASIA OF BONE; HUMANS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79960000435     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1081-2     Document Type: Article

References (34)

1. Hogendoorn PCW, Hashimoto H (2002) Adamantinoma. In: Fletcher C, Unni K, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, pp 332-334
2. Unni KK, Inwards YI, Bridge AN, Kindblom LG, Wold EW (2005) Tumors of the bones and joints AFIP atlas of tumor pathology. AFIP, pp. 281-298
3. Vigorita VJ, Whelman B, Hogendoorn PCW (2002) Osteofibrous dysplasia. In: Fletcher C, Unni K, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, pp 332-334
4. MS Benassi L Campanacci G Gamberi C Ferrari P Picci L Sangiorgi M Campanacci 1994 Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis Histopathology 25 71 76 7525449 10.1111/j.1365-2559.1994.tb00600.x 1:STN:280:DyaK2M%2FkvVahsw%3D%3D (Pubitemid 24246476)
5. HM Hazelbag GJ Fleuren LJCM Van den Broek AHM Taminiau PCW Hogendoorn 1993 Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis Am J Surg Pathol 17 1225 1233 7694513 10.1097/00000478-199312000-00003 1:STN:280:DyaK2c%2Flslajug%3D%3D (Pubitemid 23344626)
6. T Ishida T Iijima F Kikuchi T Kitagawa T Tanida T Imamura R Machinami 1992 A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones Skeletal Radiol 21 493 502 1281557 1:STN:280:DyaK3s7gt1SitA%3D%3D
7. HM Hazelbag AHM Taminiau GJ Fleuren PCW Hogendoorn 1994 Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior J Bone Joint Surg Am 76 1482 1499 7929496 1:STN:280:DyaK2M%2FhsVKhtA%3D%3D (Pubitemid 24355965)
8. S Breiteneder-Geleff K Matsui A Soleiman P Meraner H Poczewski R Kalt G Schaffner D Kerjaschki 1997 Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis Am J Pathol 151 1141 1152 9327748 1:CAS:528:DyaK2sXmvFGmu7s%3D (Pubitemid 27424324)
9. S Breiteneder-Geleff A Soleiman H Kowalski R Horvat G Amann E Kriehuber K Diem W Weninger E Tschachler K Alitalo D Kerjaschki 1999 Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium Am J Pathol 154 385 394 10027397 10.1016/S0002-9440(10)65285-6 1:STN:280:DyaK1M7kvFKnsQ%3D%3D (Pubitemid 29094089)
10. AK Rishi M Joyce-Brady J Fisher LG Dobbs J Floros J VanderSpek JS Brody MC Williams 1995 Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives Dev Biol 167 294 306 7851650 10.1006/dbio.1995.1024 1:CAS:528:DyaK2MXjs1eksLk%3D
11. A Wetterwald W Hoffstetter MG Cecchini B Lanske C Wagner H Fleisch M Atkinson 1996 Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes Bone 18 125 132 8833206 10.1016/8756-3282(95)00457-2 1:CAS:528:DyaK28XisVGjs7c%3D (Pubitemid 26092592)
12. V Schacht SS Dadras LA Johnson DG Jackson YK Hong M Detmar 2005 Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors Am J Pathol 166 913 921 15743802 10.1016/S0002-9440(10)62311-5 1:CAS:528: DC%2BD2MXivVOmsbk%3D (Pubitemid 40315647)
13. Y Shimada G Ishii K Nagai N Atsumi S Fujii A Yamada Y Yamane T Hishida M Nishimura J Yoshida N Ikeda A Ochiai 2009 Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung Cancer Sci 100 2054 2059 19681903 10.1111/j.1349-7006.2009.01295.x 1:CAS:528:DC%2BD1MXhsVSktLbO
14. T Ariizumi A Ogose H Kawashima T Hotta GD Li YJ Xu H Umezu M Sugai N Endo 2010 Expression of podoplanin in human bone and bone tumors: new marker of osteogenic and chondrogenic bone tumors Pathol Int 60 193 202 20403045 10.1111/j.1440-1827.2009.02510.x 1:CAS:528:DC%2BC3cXlt1Sjtbw%3D
15. J Shibahara T Kashima Y Kikuchi A Kunita M Fukayama 2006 Podoplanin is expressed in subsets of tumors of the central nervous system Virchows Arch 448 493 499 16411134 10.1007/s00428-005-0133-x 1:CAS:528:DC%2BD28XjtFamsL8%3D
16. JR Edwards K Williams LG Kindblom JM Meis-Kindblom PCW Hogendoorn D Hughes RG Forsyth D Jackson NA Athanasou 2008 Lymphatics and bone Hum Pathol 39 1 49 55 17904616 10.1016/j.humpath.2007.04.022 (Pubitemid 350216159)
17. AN Kalof K Cooper 2009 D2-40 immunohistochemistry-so far! Adv Anat Pathol 16 62 64 19098468 10.1097/PAP.0b013e3181915e94 1:CAS:528:DC%2BD1cXhsFWrs7jK
18. N Kimura I Kimura 2005 Podoplanin as a marker for mesothelioma Pathol Int 55 83 86 15693854 10.1111/j.1440-1827.2005.01791.x 1:CAS:528: DC%2BD2MXivVymurk%3D (Pubitemid 40343728)
19. P Gonzalez-Alva A Tanaka Y Oku Y Miyazaki E Okamoto M Fujinami N Yoshida K Kikuchi F Ide H Sakashita K Kusama 2010 Enhanced expression of podoplanin in ameloblastomas J Oral Pathol Med 39 103 109 19691459 10.1111/j.1600-0714.2009. 00818.x 1:CAS:528:DC%2BC3cXitVWjsLo%3D
20. B Czerniak RR Rojas-Corona HD Dorfman 1989 Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia Cancer 64 2319 2334 2804923 10.1002/1097-0142(19891201)64:11<2319::AID-CNCR2820641123>3.0.CO;2-0 1:STN:280:DyaK3c%2FjtVWgtQ%3D%3D (Pubitemid 19282851)
21. DS Springfield AE Rosenberg HJ Mankin ER Mindell 1994 Relationship between osteofibrous dysplasia and adamantionma Clin Orthop Relat Res 309 234 244 7994967
22. RL Kempson 1966 Ossifying fibroma of the long bones. A light and electron microscopic study Arch Pathol 82 218 233 5944441 1:STN:280:DyaF287ms1Kqsg%3D%3D
23. CJ Campbell T Hawk 1982 A variant of fibrous dysplasia (osteofibrous dysplasia) J Bone Joint Surg Am 64 231 236 7035460 1:STN:280: DyaL387itVaisw%3D%3D (Pubitemid 12132614)
24. S Hopyan N Gokgoz RS Bell IL Andrulis BA Alman JS Wunder 1999 Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours J Orthop Res 17 633 638 10569470 10.1002/jor.1100170503 1:CAS:528:DyaK1MXotVSmu78%3D
25. JVMG Bovee LJCM van den Broek WI de Boer PCW Hogendoorn 1998 Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis J Pathol 184 24 30 9582523 10.1002/(SICI)1096- 9896(199801)184:1<24::AID-PATH952>3.0.CO;2-W 1:CAS:528: DyaK1cXpt1Khug%3D%3D (Pubitemid 28086149)
26. HM Hazelbag LJCM Van den Broek GJ Fleuren AHM Taminiau PCW Hogendoorn 1997 Distribution of extracellular matrix components in adamantinoma of long bones suggests fibrous-to-epithelial transformation Hum Pathol 28 183 188 9023400 10.1016/S0046-8177(97)90104-0 1:STN:280:DyaK2s7nsFOntw%3D%3D (Pubitemid 27069184)
27. Lichtenstein L (1997) Dermal inclusion tumours in bone (so-called adamantinoma of limb bones). In: Lichtenstein L (ed) Bone Tumours. C.V. Mosby Co., St. Louis, pp 355-362
28. C Povysil Z Matejovsky 1981 Ultrastructure of adamantinoma of long bones Virchows Arch A Pathol Anat Histol 393 233 244 6270877 10.1007/BF00431079 1:STN:280:DyaL38%2FktFCgtA%3D%3D (Pubitemid 11015815)
29. A Wicki G Christofori 2007 The potential role of podoplanin in tumour invasion Br J Cancer 96 1 5 17179989 10.1038/sj.bjc.6603518 1:CAS:528: DC%2BD2sXis1Kgtg%3D%3D (Pubitemid 46094630)
30. A Wicki F Lehembre N Wick B Hantusch D Kerjaschki G Christofori 2006 Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton Cancer Cell 9 261 272 16616332 10.1016/j.ccr.2006.03.010 1:CAS:528:DC%2BD28XjvFeiurw%3D
31. M Maki N Athanasou 2004 Osteofibrous dysplasia and adamantinoma: correlation of proto-oncogene product and matrix protein expression Hum Pathol 35 69 74 14745727 10.1016/j.humpath.2003.07.008 1:CAS:528:DC%2BD2cXntVKmtA%3D%3D (Pubitemid 38133925)
32. M Durchdewald J Guinea-Viniegra D Haag A Riehl P Lichter M Hahn EF Wagner P Angel J Hess 2008 Podoplanin is a novel fos target gene in skin carcinogenesis Cancer Res 68 6877 6883 18757399 10.1158/0008-5472.CAN-08-0299 1:CAS:528:DC%2BD1cXhtVCrs77P
33. M Maki K Saitoh Y Kaneko M Fukayama T Morohoshi 2000 Expression of cytokeratin 1, 5, 14, 19 and transforming growth factors-beta1, beta2, beta3 in osteofibrous dysplasia and adamantinoma: a possible association of transforming growth factor-beta with basal cell phenotype promotion Pathol Int 50 801 807 11107052 10.1046/j.1440-1827.2000.01114.x 1:CAS:528:DC%2BD3cXos1Orsrk%3D
34. A Sakamoto Y Oda Y Iwamoto M Tsuneyoshi 2007 Frequent immunoexpression of TGF-beta1, FGF-2 and BMP-2 in fibroblast-like cells in osteofibrous dysplasia Oncol Rep 17 531 535 17273729 1:CAS:528:DC%2BD2sXivF2hu7w%3D